164 related articles for article (PubMed ID: 29800077)
1. Subacute nodopathy with conduction blocks and anti-neurofascin 140/186 antibodies: an ultrastructural study.
Vallat JM; Mathis S; Magy L; Bounolleau P; Skarzynski M; Heitzmann A; Manso C; Devaux J; Uncini A
Brain; 2018 Jul; 141(7):e56. PubMed ID: 29800077
[No Abstract] [Full Text] [Related]
2. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
4. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance.
Vural A; Doppler K; Meinl E
Front Immunol; 2018; 9():1029. PubMed ID: 29867996
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
Devaux JJ
Am J Pathol; 2012 Oct; 181(4):1402-13. PubMed ID: 22885108
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.
Querol L; Devaux J; Rojas-Garcia R; Illa I
Nat Rev Neurol; 2017 Sep; 13(9):533-547. PubMed ID: 28708133
[TBL] [Abstract][Full Text] [Related]
8. Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies.
Vallat JM; Yuki N; Sekiguchi K; Kokubun N; Oka N; Mathis S; Magy L; Sherman DL; Brophy PJ; Devaux JJ
Neuromuscul Disord; 2017 Mar; 27(3):290-293. PubMed ID: 27986399
[TBL] [Abstract][Full Text] [Related]
9. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
10. Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy.
Tard C; Maurage CA; de Paula AM; Cassim F; Delval A; Kuchcinski G; Davion JB; Defebvre L; Bouchiba M; ; Jourdain M; Boucraut J
Neurophysiol Clin; 2020 Oct; 50(5):397-399. PubMed ID: 33190687
[No Abstract] [Full Text] [Related]
11. [The significance of autoantibodies against nodal and paranodal proteins in autoimmune nodopathies].
Ogata H
Rinsho Shinkeigaku; 2023 Nov; 63(11):715-724. PubMed ID: 37880115
[TBL] [Abstract][Full Text] [Related]
12. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.
Kouton L; Boucraut J; Devaux J; Rajabally YA; Adams D; Antoine JC; Bourdain F; Brodovitch A; Camdessanché JP; Cauquil C; Ciron J; Dubard T; Echaniz-Laguna A; Grapperon AM; Juntas-Morales R; Kremer L; Kuntzer T; Labeyrie C; Lanfranco L; Léger JM; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Merle P; Noury JB; Rouaud V; Tard C; Théaudin M; Vallat JM; Viala K; Attarian S; Delmont E
Clin Neurophysiol; 2020 Apr; 131(4):921-927. PubMed ID: 32078921
[TBL] [Abstract][Full Text] [Related]
14. Nodopathy: chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 antibodies.
Kuwabara S; Misawa S; Mori M
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):459. PubMed ID: 28108521
[No Abstract] [Full Text] [Related]
15. Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies.
Kuwabara S; Misawa S; Mori M
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):707. PubMed ID: 25758172
[No Abstract] [Full Text] [Related]
16. Growing Spectrum of Autoimmune Nodopathies.
Gupta P; Mirman I; Shahar S; Dubey D
Curr Neurol Neurosci Rep; 2023 May; 23(5):201-212. PubMed ID: 37014546
[TBL] [Abstract][Full Text] [Related]
17. ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.
Illa I
J Peripher Nerv Syst; 2017 Dec; 22(4):418-424. PubMed ID: 29065233
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Martín-Aguilar L; Lleixà C; Pascual-Goñi E; Caballero-Ávila M; Martínez-Martínez L; Díaz-Manera J; Rojas-García R; Cortés-Vicente E; Turon-Sans J; de Luna N; Suárez-Calvet X; Gallardo E; Rajabally Y; Scotton S; Jacobs BC; Baars A; Cortese A; Vegezzi E; Höftberger R; Zimprich F; Roesler C; Nobile-Orazio E; Liberatore G; Hiew FL; Martínez-Piñeiro A; Carvajal A; Piñar-Morales R; Usón-Martín M; Albertí O; López-Pérez MÁ; Márquez F; Pardo-Fernández J; Muñoz-Delgado L; Cabrera-Serrano M; Ortiz N; Bartolomé M; Duman Ö; Bril V; Segura-Chávez D; Pitarokoili K; Steen C; Illa I; Querol L
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34728497
[TBL] [Abstract][Full Text] [Related]
19. Nodes, paranodes and neuropathies.
Fehmi J; Scherer SS; Willison HJ; Rinaldi S
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):61-71. PubMed ID: 28819062
[TBL] [Abstract][Full Text] [Related]
20. Teaching Neuro
Franques J; Chapon F; Devaux J; Mathis S
Neurology; 2017 Feb; 88(7):e52. PubMed ID: 28193760
[No Abstract] [Full Text] [Related]
[Next] [New Search]